Member Info for squadraazzura

There are two events that took the share price up: 1/ The Sky interview and 2/ The job offer for 20 people. All this shows the confidence around ODX. So as someone said, they should have let things run as per market sentiments. When a stock drops, nobody tries to rescue the share price In this case did the CEO, without realising, rescue a few trapped shorters ? Who knows ? But again as soon as things are confirmed, the share price will double in a few days when one looks at what happened with Avcta and Ncyt for example. Let's assume this is an opportunity for new PI's left behind this morning.

Who would want to be out ? RNS, then then the ride during the week while analysts are assessing the huge impact this will to to ODX.

I would add that no other has the government backing, expertise or logistics to rival UK - RTC.

Those who understand ODX real prospects (when compared to those that went up already 3000%+), are topping up, not selling. SP blips and transient daily, movements should not distract people at all. Just keep cool, wait then look at the SP in a few weeks time.

At this rate, the SP could hit 100p tomorrow and 150p to 200p by next week within any announcement.

People are piling in from other stocks in the same sector as they reached their full peaks while we are just starting on here. IMO 120p by Friday while waiting the RNS.

The market and savvy analysts and PI's are starting to understand the importance of antibody testing and for how long antibody testing will last - Maybe for years and I am not joking when one looks at mini spikes, secondary waves and contaminations happening around the world. The question will always be: How do we let people go to work or travel ? The only tool is antibody testing.

I think the next step id no vaccine is found is FOREVER antibody monitoring everywhere. Meaning the sky is the limit for ODX because it will be the main owner of a POC convenient test kit.

I already predicted that there will be huge migrations by PI's to ODX from other stocks in this sector because many have reached their peaks and need now to start delivering. For example AVCT market cap is now 400 million. ODX is just starting the journey and its involvement in antibody testing is even bigger than antigen testing during the de-confinement. It also helps research understand the duration of immunity. So ODX will contribute to central databases all over the world to assess the role of antibodies in the self-immunisation of individuals. So if one thinks about it, antibody testing will go on and on without any deadline or limit even after a vaccine is found because you need again to take out those with antibodies as a vaccine wouldn't work on them.

The problem with this virus is it is silently lingering around with unpredictable spikes. The vaccine may take a long time or may even never come. So the only available tool to checking who is safe to work and to travel is antibody testing. Then it is crucial to following all those people with antibodies to determine the average duration of immunity on each person. This is important to R & D in this area. I think work on antibodies will accelerate during the spread of this virus and will take pharmas a long time to understand its processes to help the industry to manufacture specific vaccines. This could even help to unlock a vaccine against HIV. I think ODX will be very busy indeed for many years to come. This Covid 19 has opened many cans of worms in the weakness of the world in containing pandemics.

ODX CEO just on Sky News.

Guys, that's a lot of people to recruit without huge orders. Then on a permanent basis too.

So far antigen tests (involving blood) are all lab based tests. In fact I cannot see why ODX wouldn't combine the two in one POC test provided it cooperates with others involved in antigen testing. If not possible with one kit they can design a second test kit for antigen POC testing. At the end of the day ODX is a pure diagnostic test company.

I would add that ODX is developing a POC ANTIBODY test (to check is someone HAD the virus and thus naturally immunised) while Avacta an antigen test (tells you if someone HAS the virus) . ODX test helps during de-confinement (when the rate of infection is dropping to allow the return to work/travel) while Avacta test helps in the confinement period (when the rate of infection is rising). However, ODX test will remain for a longer period because it is the only tool available to allow people to work. For example, a person with antibodies will not contaminate others while a person tested negative, virus free can be contaminated the next minute if he/she is in contact with an infected person. IMO antibody testing will be more valuable and will become a routine in every country. Antigen testing will continue in a supportive role to antibody testing. For example, if a person is tested negative for antibodies, THEN that person must be antigen tested to check if she has the virus or not.

Roughly, Avacta develops diagnostic reagents for COVID-19 ANTIGEN testing. It partners with others to develop and offer a saliva based swab test. So far I haven't seen any approval or any result about accuracy and sensitivity of this test on a large human sample. ODX is technically gathering and adapting biological & statistical inputs from partners into the design and freeze of a POC test. The UK-RTC comprises the University of Oxford, Abingdon Health Limited, BBI Solutions Limited and CIGA Healthcare Limited, all working in conjunction with ODX. This is supported by the government under the "Memorandum of Understanding - COVID-19 Consortium" scheme.

Merchantbanker: Excellent comprehensive post ! Agree totally with you because it looks like the vaccine won't be an easy ride for a while. Then even if we had a vaccine available, we need to eliminate those with antibodies because a vaccine wont' work on them. So testing for antibodies will be in great demand as so far, it is the only hope left while waiting for the vaccine. More people are found with antibodies is equivalent to less virus spreading. So testing for antibodies will become a routine for many years to come. 2 reasons: 1/ To clear the person for work and travel etc. and 2/ To feed the results to databases for monitoring the trend because we need to understand for how long a person with antibodies is protected. Thus following a person with antibodies means regular testing. If we replicate this process to continents plus repetitive testing for monitoring, we are talking about billions tests required. Business wise for ODX, nobody can quantify the huge impact on its numbers.

Cheers PDMSPiper - Important reading for those who haven't yet understood the importance of antibody testing is also here: https://www.gov.uk/government/news/government-to-offer-antibody-tests-to-health-and-social-care-staff-and-patients-in-england

milanelo - We shall see what's going to happen during second waves while people drop their guards and other continents/regions where it is just starting. Regardless the data on antibodies is needed to understand who had the virus and how and for how long these were protected. It will never end with antibodies.

Smokinjoe - When this happens, ODX will be the only POC test on offer. I am looking at exports all over the world. Every airport, factory, railways station, etc will order thousands. India, Africa and South America will need such easy to use piece of equipment.

Wonder what's hidden behind this statement: "My advice would be to wait until we have better tests which will be available in a similar form very soon, though they are still under evaluation at the moment."